Holen Sie sich die Stockscreener-App
89.03
1.37%
-1.21
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$90.24
Offen:
$89.61
24-Stunden-Volumen:
2.06M
Relative Volume:
0.27
Marktkapitalisierung:
$114.06B
Einnahmen:
$33.54B
Nettoeinkommen (Verlust:
$4.66B
KGV:
24.59
EPS:
3.62
Netto-Cashflow:
$5.19B
1W Leistung:
-4.24%
1M Leistung:
+0.28%
6M Leistung:
-2.00%
1J Leistung:
+10.57%
1-Tages-Spanne:
$88.69
$89.96
1-Wochen-Bereich:
$88.69
$92.75
52-Wochen-Spanne:
$79.29
$96.25
Medtronic Plc Stock (MDT) Company Profile
Firmenname
Medtronic Plc
Sektor
Branche
Telefon
01135314381700
Adresse
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Vergleichen Sie MDT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
89.02 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
ABT
Abbott Laboratories
|
127.59 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
105.67 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
378.19 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
EW
Edwards Lifesciences Corp
|
78.75 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-30 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2025-06-16 | Eingeleitet | Leerink Partners | Outperform |
| 2025-03-04 | Hochstufung | Citigroup | Neutral → Buy |
| 2024-10-10 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-08-21 | Bestätigt | Oppenheimer | Perform |
| 2024-08-15 | Hochstufung | UBS | Sell → Neutral |
| 2024-08-14 | Herabstufung | Stifel | Buy → Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Neutral |
| 2023-06-30 | Eingeleitet | CL King | Buy |
| 2023-05-30 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2023-04-24 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-03-29 | Herabstufung | UBS | Buy → Sell |
| 2023-01-09 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-11-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-11-23 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2022-11-16 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-10-18 | Eingeleitet | Barclays | Equal Weight |
| 2022-10-13 | Eingeleitet | Mizuho | Buy |
| 2022-10-12 | Eingeleitet | Jefferies | Hold |
| 2022-08-24 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2022-07-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-06-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-27 | Herabstufung | Needham | Buy → Hold |
| 2022-04-13 | Herabstufung | Truist | Buy → Hold |
| 2022-03-02 | Fortgesetzt | BofA Securities | Buy |
| 2022-01-10 | Herabstufung | BTIG Research | Buy → Neutral |
| 2022-01-07 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-01-04 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-12-16 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2021-12-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-06-10 | Fortgesetzt | Cowen | Outperform |
| 2021-05-25 | Eingeleitet | Barclays | Equal Weight |
| 2021-04-15 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-12-15 | Hochstufung | Goldman | Sell → Neutral |
| 2020-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2020-10-08 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2020-10-08 | Hochstufung | Stifel | Hold → Buy |
| 2020-09-11 | Eingeleitet | Wolfe Research | Peer Perform |
| 2020-05-14 | Herabstufung | DZ Bank | Buy → Hold |
| 2020-03-30 | Herabstufung | Needham | Strong Buy → Buy |
| 2020-03-25 | Hochstufung | DZ Bank | Hold → Buy |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-13 | Eingeleitet | Goldman | Sell |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2020-01-02 | Hochstufung | Guggenheim | Neutral → Buy |
| 2019-06-05 | Hochstufung | Wells Fargo | Market Perform → Outperform |
| 2019-02-04 | Bestätigt | Needham | Strong Buy |
| 2019-01-03 | Eingeleitet | Deutsche Bank | Buy |
| 2019-01-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2018-12-19 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2018-11-28 | Eingeleitet | UBS | Buy |
| 2018-10-16 | Eingeleitet | Barclays | Overweight |
| 2018-08-27 | Bestätigt | Argus | Buy |
Alle ansehen
Medtronic Plc Aktie (MDT) Neueste Nachrichten
Orchestra BioMed secures $70 million from Ligand and Medtronic By Investing.com - Investing.com UK
What markets is GDRX expanding into Is Medtronic plc stock a good long term investment option - jammulinksnews.com
Ligand and Medtronic Commit $70 Million in Strategic Capital to Orchestra BioMed - GlobeNewswire
$70M Strategic Investment Powers Orchestra BioMed's Revolutionary Leadless Pacemaker Technology - Stock Titan
What are the technical indicators suggesting about Medtronic plcLow Risk Recommendation With High Returns - jammulinksnews.com
What is Medtronic plc company’s growth strategyChart Pattern Growth Plan For Every Investor - jammulinksnews.com
Diabetes Care Devices Market Size Projects USD 76.44 Billion by 2034 - GlobeNewswire Inc.
Medtronic: Growth Challenges Persist (NYSE:MDT) - Seeking Alpha
Why Is Medtronic Exiting Diabetes? - Medical Device and Diagnostic industry
Will Medtronic Bring the Renal Denervation Market to the Forefront? - Medical Device and Diagnostic industry
What the charts say about Medtronic plc todayDaily Smart Money Movement Monitor Activated - metal.it
Bollinger Bands Show Potential Breakout in Medtronic plcLow Risk Equity Screener With Results Shared - metal.it
Mizuho Lifts PT on Medtronic (MDT) to $100 From $98, Keeps an Outperform Rating - MSN
Why Medtronic (MDT) is One of the Most Trusted Safe Dividend Stocks in Healthcare - Yahoo Finance
What are Medtronic plc company’s key revenue driversFinancial News Target Finder For Smart Trading - jammulinksnews.com
Medtronic (MDT) Stock Sinks As Market Gains: What You Should Know - Nasdaq
Why is Medtronic plc stock attracting strong analyst attentionRetirement Planning Review With Proven Results - jammulinksnews.com
Medtronic shares snapped six-session winning streak (NYSE:MDT) - Seeking Alpha
What are analysts’ price targets for Medtronic plc in the next 12 monthsAI Powered Growth Plan From AI Tools - jammulinksnews.com
Is it the right time to buy Medtronic plc stockUnlock powerful investment tools for free - jammulinksnews.com
When is Medtronic plc stock expected to show significant growthAchieve fast wealth growth with smart picks - jammulinksnews.com
How does Medtronic plc generate profit in a changing economyGrow your portfolio with growth-oriented stocks - jammulinksnews.com
How many analysts rate Medtronic plc as a “Buy”Dynamic investment growth - jammulinksnews.com
What institutional investors are buying Medtronic plc stockPhenomenal returns - jammulinksnews.com
Published on: 2025-07-28 01:52:57 - jammulinksnews.com
Should I hold or sell Medtronic plc stock in 2025Build a winning portfolio with smart picks - jammulinksnews.com
How does Medtronic plc compare to its industry peersBreakout stock performance - jammulinksnews.com
What makes Medtronic plc stock price move sharplyElite Investor Club - Metal.it
Medtronic plc (MDT): A Bull Case Theory - MSN
What analysts say about Medtronic plc stockHigh-yield trading alerts - PrintWeekIndia
Medtronic takes next step to submit bone graft for new FDA indication - MassDevice
Telemetric Devices Market Set to Witness Significant Growth - openPR.com
Here's What to Expect From Medtronic's Next Earnings Report - MSN
U.S. Acute External Ventricular Drain Market Analysis Report 2025-2030 Featuring Medtronic, Integra, LifeSciences, Anuncia Medical, Natus, Fuji Systems, B Braun/Aesculap, Boston Scientific, Abbott - Yahoo Finance
Medtronic's Fiscal Q1 2026 Earnings Preview: What to ExpectNews and Statistics - IndexBox
Here's What To Expect From Medtronic's Next Earnings Report - Barchart.com
Medtronic receives Type 2 label expansion for MiniMed 780G in Europe - MedTech Dive
Medtronic plc (NYSE:MDT) is largely controlled by institutional shareholders who own 87% of the company - simplywall.st
Insulin Pumps Market Outlook Report 2025, with Leading Player Profiles for Medtronic, Insulet, Tandem Diabetes Care, and More - uk.finance.yahoo.com
What drives Medtronic plc stock priceDynamic profit opportunities - Autocar Professional
Medtronic plc Stock Analysis and ForecastFree Wealth Planning Blueprint - Autocar Professional
Is Medtronic plc a good long term investmentMarket-crushing profits - jammulinksnews.com
Finanzdaten der Medtronic Plc-Aktie (MDT)
Umsatz
Nettogewinn
Free Cashflow
ENV
3.88%
0.75%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):